Pages that link to "Q44644285"
Jump to navigation
Jump to search
The following pages link to Meta-analysis of randomized controlled trials of simplified versus continued protease inhibitor-based antiretroviral therapy in HIV-1-infected patients (Q44644285):
Displaying 14 items.
- Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV (Q24202180) (← links)
- Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV (Q24239828) (← links)
- Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment (Q24803596) (← links)
- Long-term CD4 T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI (Q33803473) (← links)
- Switching Antiretroviral Therapy to Minimize Metabolic Complications (Q35608074) (← links)
- Update on HIV lipodystrophy (Q35833512) (← links)
- Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial (Q35965722) (← links)
- Treatment of dyslipidaemia in HIV-infected persons (Q36222023) (← links)
- Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy (Q36614066) (← links)
- Efavirenz: a review (Q36787311) (← links)
- Switching antiretroviral regimes for the treatment of HIV: safety implications (Q38879406) (← links)
- Metabolic changes associated with antiretroviral therapy in HIV-positive patients (Q46118009) (← links)
- A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral load. (Q46698308) (← links)
- Effectiveness and safety of simplification therapy with once-daily tenofovir, lamivudine, and efavirenz in HIV-1-infected patients with undetectable plasma viral load on HAART. (Q46935128) (← links)